Enliven Therapeutics, Inc. (ELVN)
$40.98+0.86%Close
SELLCRISIS · day 18
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.9B
- Beta
- 0.24
- P/E (TTM)
- -25.85
- Short % float
- 22.70%
- Days to cover
- 5.5
- SI change
- +20.1%
- 1W
- -12.75%
- 1M
- -27.12%
- vs SPY 1W
- -13.91%
- vs SPY 1M
- -30.11%
Industry peers
FMP comparable companies · ranked by market cap
- RVMDSELLRevolution Medicines, Inc.$42.5BRECOVERYQ 30$199.87+0.87%
- INCYSELLIncyte Corporation$22.9BBEARQ 13$112.73+0.04%
- EXELBUYExelixis, Inc.$14.7BBULLQ 10$58.33+1.42%
- RLAYSELLRelay Therapeutics, Inc.$4.1BRECOVERYQ 3$18.74+2.70%
- NUVBSELLNuvation Bio Inc.$1.7BCRISISQ 4$4.88+1.01%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.5BCRISISQ 17$17.37+0.53%
- ORICSELLORIC Pharmaceuticals, Inc.$1.2BBEARQ 3$11.98-0.33%
- TYRASELLTyra Biosciences, Inc.$1.2BCRISISQ 5$20.24-0.15%
- CGEMSELLCullinan Therapeutics, Inc.$999MCRISISQ 2$16.25+0.45%
- AVBPSELLArriVent BioPharma, Inc.$703MCRISISQ -5$15.09+0.12%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
